Search

everythinglearnresearchcommunity

for

Search:↓

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

Biological therapy boosts the immune system to effectively fight melanoma.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Finasteride increases CD8+ T cells in BPH tissues.

IMG-007 helps regrow hair and reduce scalp inflammation in severe alopecia areata.

Candida antigen is an effective and promising treatment for alopecia areata.

Targeting the AhR pathway may help treat alopecia areata.

A new treatment using a DNA aptamer can promote hair growth by targeting a specific receptor.

TNF-alpha inhibitors can cause various immune-related skin issues.

Tofacitinib effectively treated a woman's complex autoimmune and autoinflammatory disorders.

Alefacept showed some effectiveness for alopecia areata but needs more research.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Tofacitinib effectively regrows hair in alopecia universalis triggered by a virus.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

CS12192 effectively treats alopecia areata with better safety than current options.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

Promising cancer treatments were found, but the manufacturer closed.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.

Tofacitinib was more effective than methotrexate for treating alopecia areata.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Leflunomide is more likely to help treat alopecia areata than cause it.